Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model

Journal of Nuclear Medicine

Volumn 37, Issue 7, 1996, Pages 1089-1093

  Okazawa, Hidehiko ^a   Yonekura, Yoshiharu ^b   Fujibayashi, Yasuhisa ^b   Mukai, Takao ^b   Nishizawa, Sadahiko ^b   Magata, Yasuhiro ^b   Ishizu, Koichi ^b   Tamaki, Nagara ^b   Konishi, Junji ^b  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

cerebral blood flow; copper 62 PTSM; PET; three compartment modeling

Indexed keywords

COPPER 62;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN SCINTISCANNING; CLINICAL ARTICLE; COMPARTMENT MODEL; FEMALE; HUMAN; ISOTOPE LABELING; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BRAIN; CEREBROVASCULAR CIRCULATION; COPPER; COPPER RADIOISOTOPES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES; ORGANOMETALLIC COMPOUNDS; OXYGEN RADIOISOTOPES; THIOSEMICARBAZONES; TOMOGRAPHY, EMISSION-COMPUTED; WATER;

EID: 0029743082     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Robinson GD, Zielinski FW, Lee AW. The zinc-62/copper-62 generator: a convenient source of copper-62 radiopharmaceuticals. Int J Appl Radiat Isot 1980;31:111-116.
2. Fujibayashi Y, Matsumoto K, Yonekura Y, Konishi J, Yokoyama A. A new zinc-62/copper-62 generator as a copper-62 source for PET radiopharmaceuticals. J Nucl Med 1989;30:1838-1842.
3. 4-methylthiosemicarbazone). Nucl Med Biol 1987; 14:59-61.
4. Green MA, Klippenstein DL, Tennison JR. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET. J Nucl Med 1988;29:1549-1557.
5. Mathias CJ, Welch MJ, Raichle ME, et al. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM. J Nucl Med 1990;31:351-359.
6. 4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. J Nucl Med 1990;31:1989-1996.
7. Shelton ME, Green MA, Mathias CJ, Welch MJ, Bergmann SR. Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography. J Nucl Med 1989;30:1843-1847.
8. Shelton ME, Green MA, Mathias CJ, Welch MJ, Bergmann SR. Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography. Circulation 1990;82:990-997.
9. Beanlands RSB, Muzik O, Mintun M, et al. The kinetics of copper-62-PTSM in the normal human heart. J Nucl Med 1992;33:684-690.
10. 62Cu-PTSM and positron emission tomography. Circulation 1993;87:173-183.
11. Okazawa H, Yonekura Y, Fujibayashi Y, et al. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET. J Nucl Med 1994;35:1910-1915.
12. 62Cu positron generator: perfusion and plasma pool images in normal subjects. Ann Nucl Med 1995;9:81-87.
13. Mathias CJ, Bergmann SR, Green MA. Development and validation of a solvent extraction technique for determination of Cu-PTSM in blood. Nucl Med Biol 1993;20:343-349.
14. Young H, Carnochan P, Zweit J, Babich J, Cherry S, Ott R. Evaluation of copper (II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model. Eur J Nucl Med 1994;21:336-341.
15. 62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging. Biol Pharm Bull 1993;16:146-149.
16. 4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging. Ann Nucl Med 1995;9:1-5.
17. 4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria: a potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET). Biol Pharm Bull 1995;18:1126-1129.
18. 62Cu-PTSM. Nucl Med Biol 1992;19:39-44.
19. Gjedde A. High- and low-affinity transport of D-glucose from blood to brain. J Neurochem 1981;36:1463-1471.
20. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
21. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 1985;5: 584-590.
22. Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. A quantitative approach to technetium-99m-hexamethylpropyleneamineoxime. Eur J Nucl Med 1992;19:195-200.
23. Moretti JL, Caglar M, Weinmann P. Cerebral perfusion imaging tracers for SPECT: which one to choose? J Nucl Med 1995;36:359-363.
24. Mathias CJ, Bergmann SR, Green MA. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin. J Nucl Med 1995;36: 1451-1455.
25. Di Rocco RJ, Silva DA, Kuczynski BL, et al. The single-pass cerebral extraction and capillary permeability-surface area product of several putative cerebral blood flow imaging agents. J Nucl Med 1993;34:641-648.
26. Minkel DT, Saryan LA, Petering DH. Structure-function correlations in the reaction of bis(thiosemicarbazonato)copper (II) complexes with Ehrlich ascites tumor cells. Cancer Res 1978;38:124-129.